Vectus Biosystems Limited (ASX:VBS)
Australia
· Delayed Price · Currency is AUD 0.125
0.00 (0.00%)
Mar 10, 2026, 11:25 AM AEST
Vectus Biosystems Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 0.09 | 0.48 | 1.14 | 1.35 | 1.3 | 1.02 | Upgrade
|
| Revenue Growth (YoY) | -89.83% | -58.00% | -15.94% | 4.19% | 27.71% | 1888.82% | Upgrade
|
| Gross Profit | 0.09 | 0.48 | 1.14 | 1.35 | 1.3 | 1.02 | Upgrade
|
| Selling, General & Admin | 1.21 | 1.5 | 2.26 | 2.59 | 2.04 | 2.07 | Upgrade
|
| Research & Development | 0.26 | 0.67 | 1.15 | 1.96 | 2.54 | 1.72 | Upgrade
|
| Operating Expenses | 1.48 | 2.18 | 3.47 | 4.59 | 4.6 | 3.8 | Upgrade
|
| Operating Income | -1.39 | -1.7 | -2.33 | -3.24 | -3.3 | -2.79 | Upgrade
|
| Interest Expense | -0.02 | -0 | -0 | -0.2 | -0.69 | -1.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -1.41 | -1.71 | -2.34 | -3.44 | -3.99 | -3.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.07 | - | - | - | - | Upgrade
|
| Pretax Income | -1.41 | -1.78 | -2.34 | -3.44 | -3.99 | -3.86 | Upgrade
|
| Net Income | -1.41 | -1.78 | -2.34 | -3.44 | -3.99 | -3.86 | Upgrade
|
| Net Income to Common | -1.41 | -1.78 | -2.34 | -3.44 | -3.99 | -3.86 | Upgrade
|
| Shares Outstanding (Basic) | 53 | 53 | 53 | 48 | 33 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 53 | 53 | 48 | 33 | 28 | Upgrade
|
| Shares Change (YoY) | 0.16% | 0.09% | 10.95% | 43.67% | 18.47% | 19.71% | Upgrade
|
| EPS (Basic) | -0.03 | -0.03 | -0.04 | -0.07 | -0.12 | -0.14 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.03 | -0.04 | -0.07 | -0.12 | -0.14 | Upgrade
|
| Free Cash Flow | -0.83 | -0.83 | -2.1 | -2.37 | -4.46 | -3.26 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.04 | -0.05 | -0.13 | -0.12 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1541.47% | -355.81% | -204.57% | -238.92% | -253.85% | -273.77% | Upgrade
|
| Profit Margin | -1566.19% | -371.67% | -205.34% | -254.09% | -307.19% | -379.30% | Upgrade
|
| Free Cash Flow Margin | -923.13% | -173.59% | -184.49% | -174.96% | -343.23% | -319.80% | Upgrade
|
| EBITDA | -1.38 | -1.69 | -2.27 | -3.19 | -3.28 | -2.77 | Upgrade
|
| EBITDA Margin | - | - | -199.41% | -235.44% | -252.30% | -272.06% | Upgrade
|
| D&A For EBITDA | 0 | 0.01 | 0.06 | 0.05 | 0.02 | 0.02 | Upgrade
|
| EBIT | -1.39 | -1.7 | -2.33 | -3.24 | -3.3 | -2.79 | Upgrade
|
| EBIT Margin | - | - | -204.57% | -238.92% | -253.85% | -273.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.